Phase 3 Respiratory Disease Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress
Respiratory DiseaseVentilator Lung; NewbornPrematurity
Ministry of Health, Saudi Arabia134 enrolled2 locationsNCT06026163
Completed
Phase 3
Effect of Vitamin D Supplementation on Cardiovascular and Respiratory Disease Event Rates, and the incidence of fractures
Non-vertebral fracturesCancerCardiovascular Disease+1 more
University of Auckland5,110 enrolled1 locationACTRN12611000402943